Presenters: Dr. Shannon Manzi
Recording Date: September 26, 2019
How to use TPMT and NUDT15 PGx
Dr. Gunter Scharer discusses how to use TPMT and NUDT15 pharmacogenetics to reduce thiopurines-related ADRs.
Insight into TPMT and NUDT15
Learn more about how TPMT and NUDT15 variants lead to thiopurines-induced toxicity and how to use pharmacogentics to reduce the adverse reactions.
Learn more about pharmacogenomics using our educational resources.